Testing the Efficacy of Viome-designed Condition-based Supplements and Viome Precision Supplements to Improve Clinical Outcomes for Mental Health Conditions
Testing the Efficacy of Viome-designed Condition-based Supplements and Viome Precision Supplements to Improve Clinical Outcomes for Mental Health Conditions
US residents who have mental health issues sign the informed consent form and are screened and enrolled for this study. Participants complete a survey upon enrollment and are randomized into one of two study arms. This study is direct to participant and will NOT utilize clinical sites.
Participants who meet the eligibility criteria are randomized into any of the two study arms including: the placebo arm or the VIOME Precision Nutrition Program (VPNP) arm.
Placebo and Viome's Precision Nutrition Program include supplements, may include dietary recommendations towards improving the symptoms associated with mental health. The trial will last approximately 4 months for each participant.
Inclusion Criteria:
Exclusion Criteria:
Unwilling to change their current diet
Prior use of Viome products or services
Antibiotic use in the previous 4 weeks
Pregnancy (current or planned in the next 4 months)
< 90 days postpartum
Breast feeding
Active infection
Unable or unwilling to use Viome's App on an iPhone or Android smartphone
Significant diet or lifestyle change in the previous 1 month
IBD diagnosis -Major psychiatric/DSM-4 disease diagnosis (e.g. Schizophrenia, Bipolar disorder, Post- traumatic Stress Disorder, Obsessive Compulsive disorder)
Use of investigational drugs, products or devices within 1 month prior to and 4 months after the start of the trial
Cancer therapy within the previous 1 year
Major surgery in the last 6 months or planned in the next 4 months
Allergies to any supplement ingredients listed in the screening survey
Currently on a specific diet: FODMAP, KETO, PALEO
Answered yes to the question, "In the past few weeks, have you wished you were dead or had thoughts about killing yourself?"
Gastrointestinal disease including:
GI surgery except:
Esophagitis
Celiac disease
GI malignancy or obstruction
Peptic Ulcer Disease
Duodenal or gastric ulcer disease
studies@viome.com(425) 300-6933
studies@viome.com(425) 300-6933